|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
18.460 +0.920 (+5.245%) | 2022/12 - Final USD($) | %Chg (Final to Final) | 2021/12 USD($) | 2020/12 USD($) | 2019/12 USD($) | 2018/12 USD($) | ||
| Turnover | 625,698,000 | 27.668% | 490,096,000 | 390,846,000 | 273,354,000 | 231,017,000 | |
| Cost of Sales | (321,615,000) | 54.937% | (207,578,000) | (134,953,000) | (93,064,000) | (72,478,000) | |
| Gross Profit | 304,083,000 | 7.633% | 282,518,000 | 255,893,000 | 180,290,000 | 158,539,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 17,617,000 | -- | (140,864,000) | (79,977,000) | (1,851,000) | (977,000) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (27,000) | -- | 0 | (599,000) | (308,000) | (201,000) | |
| Profit / (Loss) before Taxation | (431,690,000) | -16.560% | (517,363,000) | (281,900,000) | (113,690,000) | 22,700,000 | |
| Taxation | 3,719,000 | -- | (964,000) | 477,000 | (3,826,000) | (1,941,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 201,120,000 | 26.003% | 159,615,000 | 76,478,000 | 20,604,000 | 457,000 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (226,851,000) | -36.760% | (358,712,000) | (204,945,000) | (96,912,000) | 21,216,000 | |
| Net Finance Costs / (Income) | 51,000 | -- | (407,000) | 1,134,000 | (7,569,000) | (9,952,000) | |
| Depreciation & Amortisation | 64,248,000 | 34.469% | 47,779,000 | 32,895,000 | 20,642,000 | 12,934,000 | |
| Directors' Emoluments | -- | -- | 2,860,000 | 1,865,000 | 1,783,000 | 1,249,000 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -10.820 | -- | -17.670 | -10.780 | -5.230 | 1.180 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -0.057 | -- | -0.067 | -0.079 | -0.016 | 0.172 |
| NBV per share ($) | 0.478 | -- | 0.498 | 0.462 | 0.204 | 0.261 |
| Remarks: | Real time quote last updated: 02/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -226,851,000 |
| %Change | -36.760% |
| EPS / (LPS) | USD -0.108 |
| NBV Per Share ($) | USD 0.478 |